Latest Health News
US Faces Potential Loss of Measles Elimination Status Amid Surge
An international panel is evaluating if the US has lost its measles elimination status due to ongoing resurgence, achieved in 2000 after decades of vaccination efforts. South Carolina reports over 200 new cases in the last week, doubling rapidly. Physician-journalist CĂ©line Gounder highlighted the upsurge on CBS News.
Flu Vaccine Offers Moderate Protection Against Severe 2025-26 Season Strains
Interim analyses from France and China show seasonal flu vaccines provide moderate protection early in the 2025–26 season despite H3N2 subclade K dominance. These viruses differ from anticipated vaccine strains, yet vaccination curbs severe disease. Findings suggest continued importance of flu shots.
Breakthrough: Stem Cells Yield Scalable Helper T Cells for Cancer Therapies
UBC researchers developed a method to produce helper T cells from stem cells in labs, overcoming a key barrier for affordable cell therapies against cancer and infections. Cells mature fully and function like natural ones, enabling control over helper vs. killer T cell balance. Published January 7 in Cell Stem Cell.
Nasal Cells Key to Fighting Common Colds, New Study Reveals
A Cell Press Blue study shows nasal passage cell responses to rhinoviruses determine cold severity during winter surges. This explains variable illness from the most common cold cause. Findings could lead to targeted respiratory therapies.
NVIDIA and Lilly Invest $1B in AI Lab for Drug Discovery
Eli Lilly and NVIDIA announced a $1 billion, five-year AI lab to integrate pharma scientists and engineers, accelerating protein and biology models. Aims to improve target identification and reduce trial-and-error in development. Unveiled at JPMorgan Healthcare Conference.
Illumina Launches Billion Cell Atlas to Boost AI Biology Training
Illumina's dataset maps responses of 1 billion cells to CRISPR changes across 200+ disease lines, addressing AI data bottlenecks. Enables better training for cellular biology models. Released January 13, 2026.
36 Global Health Projects Funded with €215 Million for Malaria and NTDs
Global Health EDCTP3 selected 36 proposals, including malaria therapeutics and NTD vaccines, for €215 million funding. Focuses on accelerating antimalarial candidates and prophylactic vaccines. Announced January 19, 2026.
One Year After US Aid Pause, Global Health Sector Reels from Cuts
Marking one year since the Trump administration paused US global health aid for 90 days, the sector faces ongoing human costs from disrupted programs. Immediate halt exploded funding landscapes worldwide. Reflects on January 20, 2026 anniversary.
NIH Launches $250M Initiatives for Childhood Cancer, Autism, Organoids
NIH unveiled four major programs, including a $87M Standardized Organoid Modeling Center for human-relevant disease models using AI and robotics. Targets pediatric cancer, autism, and integrated health via massive datasets. Announced in September 2025.
NASA's First-Ever Medical Evacuation from ISS Highlights Space Health Risks
Crew-11 mission ended early with SpaceX Dragon return after a medical incident in early January 2026, marking NASA's first ISS medical evacuation. Underscores challenges in long-duration spaceflight health. Announced January 8.
Asymptomatic Mpox Spread More Prevalent in Africa Than Thought
New research indicates mpox spreads asymptomatically more widely in Africa, complicating containment efforts. Challenges previous assumptions on transmission dynamics. Highlights need for enhanced surveillance.
Promising New Oral Therapies Advance for Psoriasis in 2026
Icotrokinra (IL-23 blocker) and zasocitinib (TYK2 inhibitor) show superior PASI 90/100 rates in phase 3 trials over current options. Positioned to reshape plaque psoriasis treatment landscape. Dermatology advances preview for 2026.